BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25284856)

  • 1. Efficacy of targeted narrowband ultraviolet B therapy in vitiligo.
    Majid I
    Indian J Dermatol; 2014 Sep; 59(5):485-9. PubMed ID: 25284856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted ultraviolet B phototherapy in vitiligo: A comparison between once-weekly and twice-weekly treatment regimens.
    Majid I; Imran S
    Indian J Dermatol Venereol Leprol; 2015; 81(6):600-5. PubMed ID: 26515839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Whole-body and targeted narrowband ultraviolet B phototherapy effectively stabilize acral vitiligo with negligible repigmentation beyond wrists and ankles: Results from a split-body randomized controlled trial.
    Thind A; Vinay K; Mehta H; Bishnoi A; Kumaran MS; Parsad D
    Photodermatol Photoimmunol Photomed; 2024 Mar; 40(2):e12960. PubMed ID: 38480997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is targeted UVB as effective as excimer light phototherapy in treatment of vitiligo?
    Tabassum H; Majid I; Imran S
    Dermatol Ther; 2021 Sep; 34(5):e15058. PubMed ID: 34245476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Narrowband ultraviolet B radiation therapy for recalcitrant vitiligo in Asians.
    Natta R; Somsak T; Wisuttida T; Laor L
    J Am Acad Dermatol; 2003 Sep; 49(3):473-6. PubMed ID: 12963911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psoralen-narrowband UVB phototherapy for the treatment of vitiligo in comparison to narrowband UVB alone.
    Bansal S; Sahoo B; Garg V
    Photodermatol Photoimmunol Photomed; 2013 Dec; 29(6):311-7. PubMed ID: 24118425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of Childhood Vitiligo Using Tacrolimus Ointment with Narrowband Ultraviolet B Phototherapy.
    Dayal S; Sahu P; Gupta N
    Pediatr Dermatol; 2016 Nov; 33(6):646-651. PubMed ID: 27699846
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does topical tacrolimus ointment enhance the efficacy of narrowband ultraviolet B therapy in vitiligo? A left-right comparison study.
    Majid I
    Photodermatol Photoimmunol Photomed; 2010 Oct; 26(5):230-4. PubMed ID: 20831696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative efficacy between localized 308-nm excimer light and targeted 311-nm narrowband ultraviolet B phototherapy in vitiligo: A randomized, single-blind comparison study.
    Poolsuwan P; Churee C; Pattamadilok B
    Photodermatol Photoimmunol Photomed; 2021 Mar; 37(2):123-130. PubMed ID: 33047405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted broadband ultraviolet b phototherapy produces similar responses to targeted narrowband ultraviolet B phototherapy for vitiligo: a randomized, double-blind study.
    Asawanonda P; Kijluakiat J; Korkij W; Sindhupak W
    Acta Derm Venereol; 2008; 88(4):376-81. PubMed ID: 18709309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Targeted High-Intensity Medium-Band (304-312 nm) Ultraviolet B Light in Pediatric Vitiligo.
    Dong DK; Pan ZY; Zhang J; Lu XF; Jin C; Tao SQ; Yang LJ
    Pediatr Dermatol; 2017 May; 34(3):266-270. PubMed ID: 28318054
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetrahydrocurcuminoid cream plus targeted narrowband UVB phototherapy for vitiligo: a preliminary randomized controlled study.
    Asawanonda P; Klahan SO
    Photomed Laser Surg; 2010 Oct; 28(5):679-84. PubMed ID: 20961233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pilot study of combined oral minocycline and narrowband UVB phototherapy in vitiligo: A randomized, double-blind, placebo-controlled trial.
    Charoenpongpun N; Kamanamool N; Udompataikul M; Khunkhet S; Kanokrungsee S
    Dermatol Ther; 2022 Aug; 35(8):e15596. PubMed ID: 35608017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo.
    Parsad D; Kanwar AJ; Kumar B
    J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):175-7. PubMed ID: 16441626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy, predictors of response, and long-term follow-up in patients with vitiligo treated with narrowband UVB phototherapy.
    Nicolaidou E; Antoniou C; Stratigos AJ; Stefanaki C; Katsambas AD
    J Am Acad Dermatol; 2007 Feb; 56(2):274-8. PubMed ID: 17224369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acceleration of melanocyte senescence by the proinflammatory cytokines IFNγ and TNFα impairs the repigmentation response of vitiligo patients to narrowband ultraviolet B (NBUVB) phototherapy.
    Dong BQ; Liao ZK; Le Y; Jiang S; Luo LF; Miao F; Le Poole IC; Lei TC
    Mech Ageing Dev; 2023 Apr; 211():111779. PubMed ID: 36731753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical study of repigmentation patterns with either narrow-band ultraviolet B (NBUVB) or 308 nm excimer laser treatment in Korean vitiligo patients.
    Yang YS; Cho HR; Ryou JH; Lee MH
    Int J Dermatol; 2010 Mar; 49(3):317-23. PubMed ID: 20465673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of NB-UVB on noncultured melanocyte and keratinocyte transplantation in treatment of generalized vitiligo using two different donor-to-recipient ratios.
    Tawfik YM; Abd Elazim NE; Abdel-Motaleb AA; Mohammed RAA; Tohamy AMA
    J Cosmet Dermatol; 2019 Apr; 18(2):638-646. PubMed ID: 30280485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study.
    Bhatnagar A; Kanwar AJ; Parsad D; De D
    J Eur Acad Dermatol Venereol; 2007 Nov; 21(10):1381-5. PubMed ID: 17958845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoralen and narrowband UVB combination provides higher efficacy in treating vitiligo compared with narrowband UVB alone: A randomised clinical trial.
    Zabolinejad N; Maleki M; Salehi M; Ashrafi Z; Molkara S; Layegh P
    Australas J Dermatol; 2020 Feb; 61(1):e65-e69. PubMed ID: 31651037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.